middle.news
TAL Dai-ichi Life Secures Regulatory Nod for 19.9% Stake in Challenger
10:21am on Friday 18th of July, 2025 AEST
•
Financial Services
Read Story
TAL Dai-ichi Life Secures Regulatory Nod for 19.9% Stake in Challenger
10:21am on Friday 18th of July, 2025 AEST
Key Points
TAL Dai-ichi Life receives full regulatory approvals
Includes clearance from Australian Prudential Regulation Authority (APRA)
TAL to hold 19.9% equity interest in Challenger
Investment marks strategic partnership between global insurer and Challenger
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Challenger (ASX:CGF)
OPEN ARTICLE